Riverain Technologies’ ClearRead CT Software Receives CE Mark Approval
DAYTON, Ohio – Nov. 18, 2015–ClearRead CT by Riverain Technologies receives CE mark approval. ClearRead CT incorporates Riverain’s patent pending ClearRead CT Vessel Suppression used to improve nodule conspicuity and reduce reading time. Additionally, ClearRead CT identifies and characterizes nodules and is proven to enhance radiologists’ CT nodule detection accuracy in conjunction with decreasing reading time.
The ClearRead CT software will be introduced at the 2015 Radiological Society of North America (RSNA) annual meeting in Chicago, November 29th – December 3rd.
ClearRead CT utilizes patented image normalization technology, providing an enterprise ready solution for the entire healthcare network. The technology easily processes CT scans from a wide range of manufacturers and acquisition protocols.
ClearRead CT is available for sale in Europe and is currently being reviewed for clearance by the FDA.
For a demonstration or additional information, visit the Riverain Technologies booth at RSNA 2015 (#4108, South Building)